부산대학교 도서관

Meeraus W; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Joy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Ouwens M; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Mölndal, Sweden.; Taylor KS; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Venkatesan S; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Dennis J; Momentum Data, St Albans, UK.; Tran TN; Biopharmaceutical Medicine Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USA.; Dashtban A; Institute of Health Informatics, University College London, London, UK.; Fan X; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Williams R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Morris T; Medical and Scientific Affairs, BioPharmaceuticals Medical, AstraZeneca, London, UK.; Carty L; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Hoang U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Feher M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Forbes A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Hinton W; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Sanecka K; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Warsaw, Poland.; Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Anand SN; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Clifton DA; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.; Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Taylor S; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Royal College of General Practitioners Research and Surveillance Centre, London, UK. Electronic address: simon.delusignan@phc.ox.ac.uk.

Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE

Meeraus W; Wood R; Jakubanis R; Holbrook T; Bizouard G; Despres J; Correia Da Silva C; Nachbaur G; Landis SH; Punekar Y; Aguilaniu B; Ismaila AS

International Journal of COPD, Vol Volume 14, Pp 51-63 (2018)

Meeraus W; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK. Electronic address: wilhelmine.meeraus@astrazeneca.com.; Stuurman AL; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.; Durukal I; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Conde-Sousa E; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.; Lee A; Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Cambridge, UK.; Maria AS; Evidence Generation, AstraZeneca, São Paulo, Brazil.; Furtado BE; Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, São Paulo, Brazil.; Ouwens M; Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden.; Gray CM; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Valverde DA; Techtrials Healthcare Data Science, São Paulo, Brazil.; da Silva HG; Formerly BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Taylor S; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Meeraus W; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.; de Munter L; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Gray CM; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Dwivedi A; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Wyndham-Thomas C; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Ouwens M; Medical and Payor Statistics, BioPharmaceutical Business Unit, AstraZeneca, Mölndal, Sweden.; Hartig-Merkel W; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Drikite L; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Rebry G; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Carmona A; Vaccine Research Department, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO) de la Comunitat Valenciana, Salud Pública, Valencia, Spain.; Biomedical Research Consortium of Epidemiology and Public Health (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.; Stuurman AL; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Chi Nguyen TY; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.; Mena G; Preventive Medicine Department - Germans Trias i Pujol University Hospital, Badalona, Spain.; Autonomous University of Barcelona, Bellaterra, Spain.; Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; Mira-Iglesias A; Vaccine Research Department, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO) de la Comunitat Valenciana, Salud Pública, Valencia, Spain.; Biomedical Research Consortium of Epidemiology and Public Health (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.; Icardi G; Interuniversity Research Centre on Influenza and Other Transmissible Infections (CIRI-IT), Genoa, Italy.; Department of Health Sciences, University of Genoa, Italy.; Otero-Romero S; Servicio de Medicina Preventiva y Epidemiología, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Campus Hospitalari, Barcelona, Spain.; Baumgartner S; Fourth Medical Department with Infectious Diseases and Tropical Medicine, Klinik Favoriten/Kaiser-Franz-Josef Hospital, Vienna, Austria.; Martin C; Infectious Diseases Department, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.; Taylor S; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.; Bollaerts K; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

Zhang, S.; White, J.; Hunter, A.G.; Murali, S.; Hinds, D.; Fowler, A.; Gardiner, F.; Meeraus, W.; Slade, D.

In: npj Primary Care Respiratory Medicine. (npj Primary Care Respiratory Medicine, December 2023, 33(1))

Kapoor R; Evidera, PPD Singapore, 08-11, 1 Fusionopolis Walk, Singapore 138628, Singapore.; Standaert B; Faculty of Medicine and Life Sciences, University of Hasselt, Agoralaan, 3590 Diepenbeek, Belgium.; Pezalla EJ; Enlightenment Bioconsult, LLC, 140 S Beach Street, Suite 310, Daytona Beach, FL 32114, USA.; Demarteau N; Evidera, 1932 Brussels, Belgium.; Sutton K; Evidera, Melbourne, VIC 3004, Australia.; Tichy E; Evidera, H-1113 Budapest, Hungary.; Bungey G; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.; Arnetorp S; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.; Bergenheim K; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.; Darroch-Thompson D; International Market Access, Vaccines and Immune Therapies, AstraZeneca, Singapore 339510, Singapore.; Meeraus W; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.; Okumura LM; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, São Paulo 06709-000, Brazil.; Tiene de Carvalho Yokota R; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.; P95 Epidemiology & Pharmacovigilance, 3001 Leuven, Belgium.; Gani R; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.; Nolan T; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

Meeraus W; GSK, Brentford, United Kingdom.; Fu Q; GSK, Collegeville, PA, USA.; Mu G; GSK, Collegeville, PA, USA.; Fry M; GSK, Brentford, United Kingdom. mark.a.fry@gsk.com.; Frith L; GSK, Brentford, United Kingdom.; Pimenta JM; GSK, Brentford, United Kingdom.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101631999 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-1010 (Electronic) Linking ISSN: 20551010 NLM ISO Abbreviation: NPJ Prim Care Respir Med Subsets: MEDLINE

Tabberer M; GSK, Brentford, Middlesex, UK.; Wells JR; Patient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK.; Chandler D; Patient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK.; Abetz-Webb L; Patient-Centred Outcomes Assessments Ltd, Bollington, Cheshire, UK.; Zhang S; GSK Collegeville, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA. shiyuan.x.zhang@gsk.com.; Meeraus W; GSK, Brentford, Middlesex, UK.; Fowler A; GSK, Brentford, Middlesex, UK.; Slade D; GSK, Research Triangle Park, NC, USA.

Publisher: Springer International Publishing Country of Publication: Germany NLM ID: 101722688 Publication Model: Electronic Cited Medium: Internet ISSN: 2509-8020 (Electronic) Linking ISSN: 25098020 NLM ISO Abbreviation: J Patient Rep Outcomes Subsets: PubMed not MEDLINE

Meeraus, W; Numbere, B; Liu, Y; Czira, A; Zhang, W

In Value in Health January 2022 25(1) Supplement:S271-S271